Type of Spiritual Experience
A description of the experience
Exemestane, FCE-24304, (trade name Aromasin) is a drug used to treat breast cancer. It is a member of the class of drugs known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors (ERs), and are called ER-positive. They may also be called estrogen-responsive, hormonally-responsive, or hormone-receptor-positive. Aromatase is an enzyme that synthesizes estrogen. Aromatase inhibitors block the synthesis of estrogen
On Jan, 02, 2017 7,554 people reported to have side effects when taking Aromasin.
Among them, 21 people (0.28%) have Hallucinations
On Oct, 2, 2015: 4,788 people reported to have side effects when taking Aromasin. Among them, 224 people (4.68%) have Death.
Time on Aromasin when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death7.69%26.92%19.23%30.77%15.38%0.00%0.00%